Showing results (131-140 of 295) with videos related to

Sort By:
Pageof 30
European Urology Focus|October 25, 2024
Long-term Relapse and Survival in Clinical Stage I Testicular TeratomaJulian Chavarriaga, Roderick Clark, Eshetu G Atenafu, et al.
The Lancet. Oncology|June 2, 2012
A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpointsDebora Fumagalli, Philippe L Bedard, Zeina Nahleh, et al.
Investigational New Drugs|August 4, 2018
Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitorJames J Harding, Todd M Bauer, Daniel S W Tan, et al.
JAMA Oncology|June 30, 2018
Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical TrialVirginia F Borges, Cristiano Ferrario, Nathalie Aucoin, et al.
Clinical Genitourinary Cancer|September 26, 2017
Impact of Granulocyte-colony Stimulating Factor on Bleomycin-induced Pneumonitis in Chemotherapy-treated Germ Cell TumorsEdmond M Kwan, Sophie Beck, Eitan Amir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2019
Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on SurveillanceRobert J Hamilton, Madhur Nayan, Lynn Anson-Cartwright, et al.
British Journal of Cancer|January 28, 2015
A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignanciesA Spreafico, J-P Delord, L De Mattos-Arruda, et al.
NPJ Breast Cancer|June 23, 2020
Association between BMI, vitamin D, and estrogen levels in postmenopausal women using adjuvant letrozole: a prospective studyMitchell J Elliott, Marguerite Ennis, Kathleen I Pritchard, et al.
JCO Precision Oncology|April 7, 2023
Tumor-Naïve Circulating Tumor DNA as an Early Response Biomarker for Patients Treated With Immunotherapy in Early Phase Clinical TrialsEnrique Sanz-Garcia, Sofia Genta, Xiaoxi Chen, et al.
European Urology Oncology|July 7, 2019
Detection of Relapse by Low-dose Computed Tomography During Surveillance in Stage I Testicular Germ Cell TumoursPeter Chung, Martin E O'Malley, Michael A S Jewett, et al.
Pageof 30